Celgene Corporation
CELG - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$251.87M
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $251.87 Million |
|---|---|
| Enterprise Value | $10.56 Billion |
| Earnings per Share | $5.51 |
| Beta | 1.34 |
| Outstanding Shares | 706,200,000 |
Return
| Return on Equity | 76.79% |
|---|---|
| Return on Assets | 22.44% |
| Return on Invested Capital | 38.03% |
Valuation & Multiples
| P/E Ratio | 0.03 |
|---|---|
| PEG | 0.02 |
| Price to Sales | 0.0 |
| Price to Book Ratio | 0.0 |
| Enterprise Value to Revenue | 0.21 |
| Enterprise Value to EBIT | 0.76 |
| Enterprise Value to Net Income | 1 |
| Total Debt to Enterprise | 1.89 |
| Debt to Equity | 1.65 |
Revenue Sources
No data
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Bristol-Myers Squibb Company Ce
34,100 employees
CEO: Christopher S. Boerner
Bristol Myers Squibb Company (BMS) operates as a biopharmaceutical enterprise, managing the entire lifecycle of its therapeutic products, from initial discovery and development to manufacturing, marketing, and distribution. Its diverse p...